Optimization of hepatocarcinoma uptake with radiolabeled lipiodol: development of new lipiodol formulations with increased viscosity

Autor: Etienne Garin, Virginie Cadeillan, Valérie Ardisson, Sahar Bayat, Nicolas Lepareur, Stéphanie Becker, Nicolas Noiret

Publikováno v: Cancer Biotherapy and Radiopharmaceuticals
Cancer Biotherapy and Radiopharmaceuticals, Mary Ann Liebert, 2012, 27 (2), pp.149-55. ⟨10.1089/cbr.2011.1072⟩
Cancer Biotherapy and Radiopharmaceuticals, 2012, 27 (2), pp.149-55. ⟨10.1089/cbr.2011.1072⟩

International audience; The aim of this study was to develop new Lipiodol formulations with increased viscosities to augment Lipiodol embolic effect and optimize efficiency of radiolabeled Lipiodol in hepatocarcinoma treatments. New Lipiodol formulat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf52c06c4702f2b0e145761757946a20
https://hal.archives-ouvertes.fr/hal-00867018